BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Valerion Therapeutics, LLC Presents Preclinical Proof-Of-Concept Data For VAL-0417 For The Treatment Of Lafora Disease

  September 6, 2017

   · 

  3 min read
• Drug Development

  NeuroRx Awarded FDA Fast Track Designation For First Drug Regimen Targeting Suicide In Bipolar Depression

  September 6, 2017

   · 

  3 min read
• Poxel To Present Results For Imeglimin Phase IIb Study In Japan For The Treatment Of Type 2 Diabetes At The European Association For The Study Of Diabetes 53rd Annual Meeting

  September 6, 2017

   · 

  2 min read
• Business

  Pulmatrix Licenses Inhaled COPD Drug PUR0200 To Vectura

  September 6, 2017

   · 

  5 min read
• Drug Development

  Longeveron Initiates Phase IIb Stem Cell Therapy Trial To Treat Aging Frailty

  September 6, 2017

   · 

  3 min read
• Policy

  Hi-Tech Pharmacal Invalidates Five Beta-Alanine, CarnoSyn, Patents Held By NAI

  September 6, 2017

   · 

  7 min read
• Business

  Oxeia Announces Appointment Of Dr. Michael Wyand As Chief Executive Officer

  September 6, 2017

   · 

  2 min read
• Drug Development

  MacroGenics Advances Two First-In-Class Clinical DART Molecules

  September 6, 2017

   · 

  5 min read
• BioMidwest

  Two Labs Marketing Changes Name To Two Labs To Reflect Expanded Suite Of Offerings

  September 6, 2017

   · 

  2 min read
• Business

  Clinical SCORE Names Blaine Cloud As Senior Vice President

  September 6, 2017

   · 

  2 min read